Fed Regist. 2014 Jul 25;79(143):43241-6.
The Food and Drug Administration (FDA) is issuing a final order to reclassify implanted blood access devices, a preamendments class III device, into class II (special controls) based on new information and subject to premarket notification and to further clarify the identification.
美国食品药品监督管理局(FDA)正在发布一项最终命令,基于新信息将植入式血液通路装置(一种修正案前的III类装置)重新分类为II类(特殊控制),并需进行上市前通知,同时进一步明确标识。